AB Science (FRA:A8D) FFO


FRA:A8D AB Science FRA:A8D
57 GF Score
Price €0.87
GF Value €1.43
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is AB Science FFO?

FFO (Funds from operations) only applies to REITs.

FRA:A8D
57GF Score
AB Science FRA:A8D
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AB Science (FRA:A8D) Overvalued in 2026?

Based on GuruFocus' analysis, AB Science stock appears to be undervalued. The current stock price of €0.87 is trading 39.1% below its estimated GF Value™ of €1.43. GuruFocus considers AB Science to be Possible Value Trap.

Key valuation signals for FRA:A8D:

  • FFO:
  • GF Value™: €1.43 vs. price of €0.87 (39.1% below fair value)
  • GF Score™: 57/100 with 11 warning signs

No single metric tells the full story. See the FRA:A8D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AB Science Business Description

Address 3, Avenue George V, Paris, FRA, 75008
AB Science is a clinical-stage pharmaceutical company that has developed a diversified portfolio of medicines targeting unmet medical needs, based on two platforms. Masitinib platform: It is based on masitinib, a selective protein kinase inhibitor in development for neurodegenerative diseases, oncology, & inflammatory diseases. It has the clinical development of masitinib in neurodegenerative diseases (specifically Alzheimer's disease, amyotrophic lateral sclerosis, & progressive forms of multiple sclerosis). ALDH/Microtubule Platform: It is a portfolio of synthetic agents that target cancer cells by destabilising microtubules, which are essential for cell division & cancer stem cells, by inhibiting enzymes that are essential for maintaining their physiological state & survival.
57GF Score

Get the complete analysis for FRA:A8D

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.87
Price
€1.43
GF Value